Fundraising Fox
/People
Sign in

Michael Mendelsohn

InvestorFounder

Strategic Advisory Board at Broadview Ventures · Founder and Chief Strategy Officer at Cardurion

Boston, Massachusetts, United States

FoundedCardurion

Find your path to Michael

436 people in our graph can introduce you to Michael.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Samantha Berrick to introduce you to Michael

You →Samantha · together at Foghorn Therapeutics, Inc (2022–2023) →Michael

Ask Jamie Chen to introduce you to Michael

You →Jamie · 3 people · together at Tufts Medical Center →Michael

Ask Sam Okafor to introduce you to Michael

You →Sam · 8 people · together at Merck & Co →Michael

Sign up to find every way you can get introduced to Michael

  • Your email: the people you already email who know Michael
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Michael
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Founder, Chairman, and Chief Strategy Officer of Cardurion Pharmaceuticals and an internationally recognized cardiovascular physician-scientist, with prior roles at Merck and as a Venture Partner at SV Health Investors. He serves on Broadview's Strategic Advisory Board.

Founder and Chief Strategy Officer at Cardurion

Intro paths

→

In turn, Michael can intro founders to Cardurion's investors below.

Cardurion's investors · 11

Ascenta CapitalWilmington · $15M – $30M checks · since 2024Bain CapitalBain Capital Life SciencesBoston · since 2024Bain Capital Tech OpportunitiesBoston · since 2024Delos CapitalCambridge · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024Fidelity InvestmentsBoston · since 2024GV (Google Ventures)Mountain View · $250K – $50M checks · since 2024InvusNew York · since 2024Millennium ManagementNew York · since 2024New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024

Co-founders at Cardurion

MMMichael Mendelsohn, M.D.
Michael Mendelsohn, M.D.Founder

Founder at Cardurion

Intro paths

→

In turn, Michael can intro founders to Cardurion's investors below.

Cardurion's investors · 11

Ascenta CapitalWilmington · $15M – $30M checks · since 2024Bain CapitalBain Capital Life SciencesBoston · since 2024Bain Capital Tech OpportunitiesBoston · since 2024Delos CapitalCambridge · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024Fidelity InvestmentsBoston · since 2024GV (Google Ventures)Mountain View · $250K – $50M checks · since 2024InvusNew York · since 2024Millennium ManagementNew York · since 2024New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024

Co-founders at Cardurion

MEMichael E. Mendelsohn
Michael E. MendelsohnFounder and Chief Strategy Officer

Experience

  1. Cardurion PharmaceuticalsFounder and Chairmancurrent2016 — presentGreater Boston
  2. Foghorn Therapeutics, IncBoard Of Directorscurrent2016 — presentGreater Boston
  3. Mendelsohn Consulting Group LLCPresidentcurrent2013 — presentGreater Boston
  4. CyclerionBoard Of Directors2019 — 2023Greater Boston
  5. SV Life SciencesVenture Partner2014 — 2017Greater Boston
  6. Regado Biosciences-> Tobira Therapeutics (SAB member)Member of Board of Directors2013 — 2015
  7. Merck & CoSenior Vice President & Head, Atherosclerosis and Cardiovascular Research2010 — 2013
  8. Tufts Medical CenterChief Scientific Officer2008 — 2010
  9. Tufts Medical CenterExecutive Director, Molecular Cardiology Research Institute1998 — 2010
  10. Tufts UniversityElisa Kent Mendelsohn Professor of Molecular Cardiology and Medicine1998 — 2010
  11. Eon CorporationPresident and CEO1996 — 1998Boston, MA
  12. Harvard Medical School; Brigham and Women's HospitalAssistant Professor of Medicine; Cardiologist1982 — 1993

Skills & more

Cardiology45Senior Executive LeadershipMolecular & Cellular Biology4Medicine36Executive Management6Lifesciences22Drug Discovery34Clinical Trials30Early Development3Drug Design3Drug Development26Internal Medicine10
+12 moreMolecular PharmacologyCardiovascular PhysiologyHuman PhysiologyAcademic Medical Centersacademic medicinePharmaceutical IndustryBiomarkersNeurosciencePharmacologyClinical ResearchHypertensionClinical Development

From Michael's professional profile.

Colleagues at Broadview Ventures

Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Costantino Iadecola
Strategic Advisory Board at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures

Frequently asked questions

Who is Michael Mendelsohn?
Founder, Chairman, and Chief Strategy Officer of Cardurion Pharmaceuticals and an internationally recognized cardiovascular physician-scientist, with prior roles at Merck and as a Venture Partner at SV Health Investors. He serves on Broadview's Strategic Advisory Board.
Where does Michael Mendelsohn work?
Michael Mendelsohn is Founder of Cardurion and Strategic Advisory Board at Broadview Ventures.
What companies did Michael Mendelsohn found?
Michael Mendelsohn founded Cardurion.
Where did Michael Mendelsohn go to school?
Michael Mendelsohn studied at Harvard Medical School (M.D., Medicine); Amherst College (B.A., Chemistry and English).

Founder mafias

Same school

Shared employers